Platinum-based chemotherapy rechallenge or enfortumab vedotin after maintenance avelumab or pembrolizumab for locally advanced or metastatic urothelial carcinoma [0.03%]
局部晚期或转移性尿路上皮癌在维持治疗使用avelumab或pembrolizumab之后再次使用铂类化疗或enfortumab vedotin治疗
Nobutaka Nishimura,Makito Miyake,Norimi Takamatsu et al.
Nobutaka Nishimura et al.
Background: In current clinical practice, the use of switch maintenance avelumab is recommended for patients with locally advanced and metastatic urothelial carcinoma who experience favorable responses to first-line chemo...
Serum metabolomic analysis identified serum biomarkers predicting tumour recurrence after Bacillus Calmette-Guérin therapy in patients with non-muscle invasive bladder cancer [0.03%]
血清代谢组学分析识别出非肌层浸润性膀胱癌患者在卡介苗治疗后肿瘤复发的预测血清生物标志物
Makito Miyake,Kota Iida,Nobutaka Nishimura et al.
Makito Miyake et al.
Background: Metabolomic research and metabolomics-based biomarkers predicting treatment outcomes in bladder cancer remain limited. Objective: ...
Systemic induction therapy in patients with locally advanced or node-positive urothelial carcinoma: Evaluating treatment outcomes [0.03%]
局部晚期或淋巴结阳性尿路上皮癌患者的系统诱导治疗：评估治疗结果
Vera C Rutten,Jan-Jaap Mellema,Tahlita Cm Zuiverloon et al.
Vera C Rutten et al.
Background: The presence of lymph node metastases in patients with urothelial carcinoma (UC) plays a pivotal role in disease management and prognosis. Patients with locally advanced irresectable or clinically node-positiv...
Repeat TURBT in large volume high-grade non-invasive bladder cancer [0.03%]
大体积高级别非肌层浸润性膀胱癌的重复TURBT治疗
Adri M Durant,Mimi Nguyen,Mouneeb M Choudry et al.
Adri M Durant et al.
Background: The American Urological Association (AUA)/Society of Urology Oncology (SUO) guidelines recommend a repeat transurethral resection of bladder tumor (TURBT) for high-risk, non-invasive (HR Ta) nonmuscle invasive...
Achieving health equity in bladder cancer care: Addressing disparities through collaborative research and evidence-based strategies [0.03%]
实现膀胱癌治疗中的健康公平性：通过协作研究和基于证据的策略解决差异问题
Yelba Castellon-Lopez,Patricia A Thompson
Yelba Castellon-Lopez
The United States has seen a decrease in the incidence of bladder cancer and a decline in mortality rates over the past 20 years. However, not all groups have benefited equally from this trend. The American Association of Community Cancer C...
North American study and meta-analysis evaluating performance of Bladder EpiCheck®, a FDA cleared test, in non-muscle invasive bladder cancer recurrence [0.03%]
评估Bladder EpiCheck®（一种获得FDA批准的测试）在非肌层浸润性膀胱癌复发中的性能的北美研究和荟萃分析
Neil Fleshner,Herbert Barton Grossman,Ryan Berglund et al.
Neil Fleshner et al.
Background: Bladder EpiCheck (BE) is a novel methylation-based PCR urine test for the detection of non-muscle invasive bladder cancer (NMIBC) recurrences. ...
BCG therapy for bladder cancer: Exploring patient experiences and concerns through artificial intelligence-based social media analysis [0.03%]
膀胱癌的卡介苗治疗：通过基于人工智能的社会媒体分析探索患者体验和关注点
Zine-Eddine Khene,Isamu Tachibana,Raj Bhanvadia et al.
Zine-Eddine Khene et al.
Background: There is a notable disparity between the guidelines for BCG therapy in non-muscle invasive bladder cancer (NMIBC). Reddit has emerged as a popular online platform for individuals seeking information and exchan...
Antiangiogenic therapy combined with immune checkpoint blockade in urothelial cancer: Systematic review and meta-analysis [0.03%]
抗血管生成治疗联合免疫检查点阻断在尿路上皮癌中的应用：系统回顾与荟萃分析
Mohammad Jad Moussa,Iuliia Kovalenko,Emanuele Crupi et al.
Mohammad Jad Moussa et al.
Background: Antiangiogenic therapy had been tested in urothelial cancer (UC) without reaching the clinic. Objective: We provide a syste...
Single-cell RNA sequencing and spatial transcriptome analysis in bladder cancer: Current status and future perspectives [0.03%]
膀胱癌中单细胞RNA测序和空间转录组学分析：现状与未来展望
Kentaro Yoshihara,Kagenori Ito,Takahiro Kimura et al.
Kentaro Yoshihara et al.
Background: Bladder cancer is one of the most prevalent malignancies, and the mechanisms underlying its progression and the role of the tumor microenvironment (TME) are unclear. Recent advancements in single-cell RNA sequ...
Management of bladder cancer in kidney transplant recipients: A narrative review [0.03%]
肾移植受者膀胱癌的治疗：一项记叙性回顾
Khi Yung Fong,Ee Jean Lim,Wei Zheng So et al.
Khi Yung Fong et al.
Background: Bladder cancer in the setting of previous a kidney transplant (KT) is challenging to manage due to complex medical and surgical considerations. ...